Perkonigg, Matthias http://orcid.org/0000-0002-9107-4755
Hofmanninger, Johannes
Herold, Christian J.
Brink, James A.
Pianykh, Oleg http://orcid.org/0000-0002-9107-5432
Prosch, Helmut
Langs, Georg http://orcid.org/0000-0002-5536-6873
Funding for this research was provided by:
Boehringer Ingelheim
European Commission (780495, 765148)
Austrian Science Fund (P34198, P35189)
Oesterreichische Nationalbank (18207)
Novartis Pharmaceuticals Corporation
Article History
Received: 3 May 2021
Accepted: 19 August 2021
First Online: 28 September 2021
Competing interests
: Authors declare the following competing interests: M.P., J.H. and O.P. declare no competing interests. C.H.: Research Consultant for Siemens Healthineers and Bayer Healthcare, Stock holder at Hologic Inc. J.A.B.: Member of the Board of Directors for Accumen, Inc. H.P.: Speakers Honoraria for Boehringer Ingelheim and Roche. Received a research grant from Boehringer Ingelheim. G.L.: Co-founder and stock holder at contextflow GmbH. Received research funding from Novartis Pharmaceuticals Corporation.